These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9093883)

  • 1. Immunosuppression in renal transplantation.
    Bonomini V; Scolari MP; Buscaroli A; Liviano D'Arcangelo G; Stefoni S
    Int J Artif Organs; 1997 Feb; 20(2):73-5. PubMed ID: 9093883
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic renal allograft damage: existing challenges.
    Arias M; Serón D; Moreso F; Bestard O; Praga M
    Transplantation; 2011 May; 91(9 Suppl):S4-25. PubMed ID: 21519213
    [No Abstract]   [Full Text] [Related]  

  • 3. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological risks of minimization strategies.
    Snanoudj R; Tinel C; Legendre C
    Transpl Int; 2015 Aug; 28(8):901-10. PubMed ID: 25809144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early steroid withdrawal after renal transplantation.
    Colaneri J
    Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
    [No Abstract]   [Full Text] [Related]  

  • 6. State-of-the-art immunosuppression protocols for pediatric renal transplant recipients.
    Pape L
    Pediatr Nephrol; 2019 Feb; 34(2):187-194. PubMed ID: 29067527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation.
    Morrissey PE; Gohh RY; Monaco AP
    Transplant Proc; 2002 Aug; 34(5):1640-1. PubMed ID: 12176517
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplantation: new protocols and new worries.
    Grinyo JM
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
    [No Abstract]   [Full Text] [Related]  

  • 9. Update in immunosuppression.
    Huizinga R
    Nephrol Nurs J; 2002 Jun; 29(3):261-7. PubMed ID: 12164076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT3 in renal allografts: survival and complications.
    D'Souza RJ; Kwan JT; Chang R; Bending MR
    Clin Nephrol; 1999 Apr; 51(4):257-8. PubMed ID: 10230561
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic rejection of renal allografts with four immunosuppressive regimens.
    Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
    Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
    Lin CY; Yen CY
    Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
    [No Abstract]   [Full Text] [Related]  

  • 13. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
    Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
    Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidences in immunosuppression in the maintenance of renal transplantation].
    Hernández D; González-Posada JM
    Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclosporin in transplantation management--especially after kidney transplantation].
    Quellhorst E
    Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors associated with long-term renal allograft survival.
    Kaplan B; Srinivas TR; Meier-Kriesche HU
    Ther Drug Monit; 2002 Feb; 24(1):36-9. PubMed ID: 11805720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.
    Borie DC; Changelian PS; Larson MJ; Si MS; Paniagua R; Higgins JP; Holm B; Campbell A; Lau M; Zhang S; Flores MG; Rousvoal G; Hawkins J; Ball DA; Kudlacz EM; Brissette WH; Elliott EA; Reitz BA; Morris RE
    Transplantation; 2005 Apr; 79(7):791-801. PubMed ID: 15818321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppression in the kidney transplant. Old drugs and new acquisitions].
    Rodríguez Ferrero M; Valderrábano F
    Rev Clin Esp; 1997 Oct; 197(10):703-12. PubMed ID: 9424669
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical appraisal of renal transplantation.
    Diethelm AG
    Transplant Proc; 1992 Dec; 24(6):2387-90. PubMed ID: 1465804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.